Skip to main content
SpringerLink
Log in

Pathophysiology of Heart Failure in Regurgitant Valvular Diseases: Relation to Ventricular Dysfunction and Clinical Debility

  • Chapter
Molecular Cardiology in Clinical Practice

Part of the book series: Basic Science for the Cardiologist ((BASC,volume 2))

Abstract

Regurgitant valvular heart diseases and, most particularly, insufficiency of the aortic and/or mitral valves (AR, MR), are among the more common, and most predictable, causes of congestive heart failure. Current data suggest that these conditions also confer a proclivity for sudden death, even among asymptomatic or minimally symptomatic patients (1,2,3).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Borer JS, Hochreiter C, Herrold EM, Supino P, Aschermann M, Wencker D, Devereux RB, Roman MJ, Szulc M, Kligfield P, Isom OW. Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance. Circulation 1998; 97:525–534.

    PubMed  CAS  Google Scholar 

  2. Hochreiter C, Niles N, Devereux RB, Kligfield P, Borer JS. Mitral regurgitation: relationship of non-invasive descriptors of right and left ventricular performance to clinical and hemodynamic findings and to prognosis in medically and surgically treated patients. Circulation 1986;73:900–912.

    PubMed  CAS  Google Scholar 

  3. Kligfield P, Hochreiter C, Niles N, Devereux RB, Borer JS. Relation of sudden death in pure mitral regurgitation, with and without mitral valve prolapse, to repetitive ventricular arrhythmias and right and left ventricular ejection fractions. American Journal of Cardiology 1987;60:397–399.

    Article  PubMed  CAS  Google Scholar 

  4. Magid NM, Young MS, Wallerson DC, Goldweit RS, Carter JN, Devereux RB, Borer JS. Hypertrophic and functional response to experimental chronic aortic regurgitation. Journal of Molecular and Cellular Cardiology 1988;20:239–246.

    Article  PubMed  CAS  Google Scholar 

  5. Yamazaki T, Uematsu T, Mizuno A, Takiguchi Y, Nakashima M. Alterations of cardiac adrenoceptors and calcium channels subsequent to production of aortic insufficiency in rats. Arch Int Pharmacodyn Ther 1989;299:155–168.

    PubMed  CAS  Google Scholar 

  6. Weber KT, Brilla CG. Pathological hypertrophy and the cardiac interstitium. Fibrosis and the renin-angiotensin-aldosterone system. Circulation 1991; 83:1849–1865.

    PubMed  CAS  Google Scholar 

  7. Liu S-K, Magid NM, Fox PR, Goldfine SM, Borer JS. Fibrosis, myocyte degeneration and heart failure in chronic experimental aortic regurgitation. Cardiology, 1998, in press.

    Google Scholar 

  8. Reid CL, Gardin JM, Yunis C, Kurosaki T, Flack JM, for the Coronary Artery Risk Development inYoung Adults Research Group. Prevalence and clinical correlates of aortic and mitral regurgitation in young adult population: The Cardia Study. Circulation 1994;90(Suppl I):I–282(Abs).

    Google Scholar 

  9. Siemienczuk D, Greenberg B, Morris C, Massie B, Wilson RA, Topic N, Bristow JD, Cheitlin M. Chronic aortic insuffiency: factors associated with progression to aortic valve replacement. Ann Intern Med. 1989;110–587–592.

    Google Scholar 

  10. Bonow RO, Rosing DR, Mclntosh CL, Jones M, Maron BJ, Lan KKG, Lakatos E, Bacharach SL, Green MV, Epstein SE. The natural history of asymptomatic patients with aortic regurgitation and normal left ventricular function. Circulation. 1983;68:509–517.

    PubMed  CAS  Google Scholar 

  11. Linsay J, Silverman A, Van Voorhees LB, Nolan NG. Prognostic implications of left ventricular function during exercise in asymptomatic patients with aortic regurgitation. Angiology 1987;38:386–392.

    Google Scholar 

  12. Henry WL, Bonow RO, Borer JS, Ware JH, Kent KM, Redwood DR, Mclntosh CL, Morrow AG, Epstein SE. Observations on the optimum time for operative intervention for aortic regurgitation, I: evaluation of the results of aortic valve replacement in symptomatic patients. Circulation 1980;61:471–483.

    PubMed  CAS  Google Scholar 

  13. Borer JS, Hochreiter C, Herrold EM, Roman MJ, Kligfield P, Szulc M, Supino P, Isom OW, Krieger K, Kaufman JD. Prediction of outcome late after aortic valve replacement for aortic regurgitation utilizing pre-operative wall-stress-sdjusted change in ejection fraction from rest to exercise. Circulation 1998; in press (Abs).

    Google Scholar 

  14. Borer JS, Herrold EM, Hochreiter C, Roman M, Supino P, Devereux RB, Kligfield P, Nawaz H. Natural history of left ventricular performance at rest and during exercise after aortic valve replacement for aortic regurgitation. Circulation 1991;84(Suppl IH):III-133–III-139.

    CAS  Google Scholar 

  15. Enrique-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, Bailey KR, Frye RL. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation 1994;90:830–837.

    Google Scholar 

  16. Philips HR, Levine FH, Carter JE, Boucher C, Osbakken MD, Okada RD, Akins CW, Daggett WM, Buckley MJ, Pohost GM. Mitral valve replacement for isolated mitral regurgitation: analysis of clinical course and late postoperative left ventricular ejection fraction. American Journal of Cardiology 1981;48: 647–654.

    Article  Google Scholar 

  17. Rosen S, Borer JS, Hochreiter C, Supino P, Roman M, Devereux RB, Kligfield P. Natural history of the asymptomatic/minimally symptomatic patient with normal right and left ventricular performance and severe mitral regurgitation due to mitral valve prolapse. American Journal of Cardiology 1994;74:374–380.

    Article  PubMed  CAS  Google Scholar 

  18. Borer JS, Wencker D, Hochreiter C. Management decisions in valvular heart disease: the role of radionuclide-based assessment of ventricular function and performance. Journal of Nuclear Cardiology 1996:3:72–81.

    Article  PubMed  CAS  Google Scholar 

  19. Magid NM, Borer JS, Young MS, Wallerson DC, De Monteiro C. Suppression of protein degradation in progessive cardiac hypertrophy of chronic aortic regurgitation. Circulation 1993;871249–1257.

    Google Scholar 

  20. Leiden JM. The genetics of dilated cardiomyopathy-emerging clues to the puzzle. New England J Med 1997;337:1080–1081.

    Article  CAS  Google Scholar 

  21. Magid NM, Opio G, Wallerson DC, Young MS, Borer JS. Heart failure due to chronic experimental aortic regurgitation. American J Physiology 1994;267:H556–562.

    CAS  Google Scholar 

  22. Magid NM, Wallerson DC, Bent SJ, Borer JS. Hypertrophy and heart failure in chronic experimental mitral regurgitation. J American College Cardiology 1994;23(Special Issue): 248A (Abs.).

    Google Scholar 

  23. Young MS, Magid NM, Wallerson DC, Goldweit RS, Devereux RB, Carter JN, Im J, Hall MA, Borer JS. Echocardiographic left ventricular mass measurement in small animals: anotomic validation in normal and aortic regurgitant rabbits. American Journal of Noninvasive Cardiology 1990;4:145–153.

    Google Scholar 

  24. King RK, Magid NM, Opio G, Borer JS. Protein turnover in compensated chronic aortic regurgitation. Cardiology 1997;88:518–525.

    PubMed  CAS  Google Scholar 

  25. Magid NM, Opio G, Wallerson DC, Borer JS. Suppressed protein turnover in congestive heart failure due to severe chronic aortic regurgitation. Circulation 1992;86:I–540.

    Google Scholar 

  26. Carter JN, Borer JS, Jacobson MN, Herrold EM, Magid NM. Myofibrillar protein synthesis rates in mitral regurgitation. Circulation 1997;96(Suppl I): 1–469 (Abs).

    Google Scholar 

  27. Herrold EM, Lu P, Zanzonic P, Goldfine SM, Szulc M, Magid NM, Borer JS. Antimyosin antibody-mediated detection of myocardial injury: relation to wall stress in chronic aortic regurgitation. Computers in Cardiology 1995; IEEE Publication #0276-6547/95: 59–62.

    Google Scholar 

  28. Oldershaw PJ, Brooksby IAB, Davies MJ, Coltart DJ, Jenkins BS, Webb-Peploe MM: Correlations of fibrosis in endomyocardial biopsies from patients with aortic valve disease. B Heart J 1980; 44:609–611.

    Article  CAS  Google Scholar 

  29. Donaldson RM, Florio R, Rickards AF, et al: Irreversible morphological changes contributing to depressed cardiac function after surgery for chronic aortic regurgitation. B Heart J 1982;48:589–597.

    Article  CAS  Google Scholar 

  30. Hannafin JA, personal communication.

    Google Scholar 

  31. Lu P, Zanzonico P, Goldfine SM, Hardoff R, Gentile R, Magid N, Herrold EM, Borer JS. Antimyosin antibody imaging in experimental aortic regurgitation. Journal of Nuclear Cardiology 1997;4:25–32.

    Article  PubMed  CAS  Google Scholar 

  32. Herrold EM, Carter JN, Borer JS. Volume-overload-related shape change limits mass increase with wall thickening but only minimally reduces wall stress. Computers in Cardiology, 1992; IEEE publication #0276-6547/92:287–290.

    Google Scholar 

  33. Herrold EM, Goldfine SM, Magid NM, Borer JS. Myocardial blood flow in aortic regurgitation: computer-based predictions from wall stress compared with fluorescent microsphere measurements. Computers in Cardiology 1994; IEEE Publications #0276-6547/94:729–732.

    Google Scholar 

  34. Goldfine SM, Pena M, Magid NM, Liu S-K, Borer JS. Myocardial collagen in cardiac hypertrophy resulting from chronic aortic regurgitation. American Journal of Therapeutics, in press, 1998.

    Google Scholar 

  35. Borer JS, Pena M, Falcone D, Truter S, Goldfine S. Chronic aortic regurgitation causes fibrosis featuring hyper-production of non-collogen, glucosamine-containing matrix elements. J American College of Cardiology (Abstract), submitted, action pending 1999.

    Google Scholar 

  36. Goldin D, Borer JS, Goldfine SM. Abnormal gene expression of cardiac fibroblasts in experimental aortic regurgitation. Circulation 1997; 96(Suppl I): I–205(Abs).

    Google Scholar 

  37. Gimbrone MA, Nagel T, Topper JN. Biomechanical activation: an emerging paradigm in endothelial adhesion biology. J Clin Invest 1997;99:1809–1813.

    Article  PubMed  CAS  Google Scholar 

  38. Truter S, Kolesar J, Dumlao T, Borer JS. Chronic aortic regurgitation causes abnormal cardiac fibroblast gene expression leading to myocardial fibrosis. J American College Cardiology (Abs.), submitted, action pending 1999.

    Google Scholar 

  39. Liu F, Truter SL, Magda P, Borer JS. Aortic regurgitation alters the expression of dihydropyridine-sensitive L-type calcium channels in cardiac fibroblasts. J American College of Cardiology 1998; 31(Suppl A):424A(Abs.).

    Article  Google Scholar 

  40. Ross JS, Goldfine SM, Herrold EM, Borer JS. Differential response to vesnarinone by cardiac fibroblasts isolated from normal and aortic regurgitation hearts. American Journal of Therapeutics 1998, in press.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cornell Univeristy Medical College, USA

    Jeffrey S. Borer M.D., Edmund M. Herrold M.D., Ph.D., Clare A. Hochreiter M.D., Sharada L. Truter Ph.D., John N. Carter Ph.D. & Steven M. Goldfine Ph.D.

Authors
  1. Jeffrey S. Borer M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Edmund M. Herrold M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Clare A. Hochreiter M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sharada L. Truter Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. John N. Carter Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Steven M. Goldfine Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine, University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, USA

    Michael Sanders  & John B. Kostis  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Kluwer Academic Publishers

About this chapter

Cite this chapter

Borer, J.S., Herrold, E.M., Hochreiter, C.A., Truter, S.L., Carter, J.N., Goldfine, S.M. (1999). Pathophysiology of Heart Failure in Regurgitant Valvular Diseases: Relation to Ventricular Dysfunction and Clinical Debility. In: Sanders, M., Kostis, J.B. (eds) Molecular Cardiology in Clinical Practice. Basic Science for the Cardiologist, vol 2. Springer, Boston, MA. https://doi.org/10.1007/978-0-585-38141-1_3

Download citation

  • DOI: https://doi.org/10.1007/978-0-585-38141-1_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-7923-8602-5

  • Online ISBN: 978-0-585-38141-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation